BRANFORD — Connecticut’s bioscience industry has a new player.

A new genomics research facility of the New York City-based Icahn School of Medicine at Mount Sinai is setting up shop in Branford, projecting to create 142 new jobs over the next five years.

The state of Connecticut is supporting Icahn’s 16,500-square-foot facility with a $9.5 million loan administered by the state’s Department of Economic & Community Development (DECD). That loan could be forgiven by up to $7.25 million if the company hits its job-creation target.

The Branford facility will continue DNA testing, research and clinical tests for diseases such as cancer, diabetes and Alzheimer’s. Genomic medicine analyzes sequencing of individual DNA, RNA, blood, tumor and other samples to more accurately define a patient’s condition, leading to more specific and presumably more helpful treatments.

The Icahn School of Medicine at Mount Sinai was founded in New York City in 1963.